4c3c0620-4349-483a-acbc-f15f938c5c07-hero-1.jpg

Nanobodies® – creating better medicines

Learn More
3709f05d-3fb3-4954-8080-36e22f6218fb-hero-2.jpg

The properties of Nanobodies offer significant competitive advantages

Learn More
ab442429-f046-43ef-9cc8-983f7564ce77-hero-3.jpg

Ablynx has many established partnerships with leading pharmaceutical companies

Learn More

Ablynx is dedicated to creating new medicines which will make a real difference to society

Our Products

Our Products

The Company has more than 30 proprietary and partnered product candidates in development

Learn more.
Webcasts

Webcasts

Ablynx organises webcasts for analysts and investors on the occasion of financial results

Learn more.
Investors

Investors

Ablynx is listed on Euronext Brussels under the ticker symbol ABLX.

Learn more.

Stock Quote

ABLX

€ 10.66

0.19  +1.77%

Updated at 15:59 CET

Video

Ablynx’s proprietary Nanobody platform allows for the rapid generation and large-scale production of novel biological therapeutics that have potential in a wide range of human diseases.

Ablynx on YouTube >>